President Donald Trump supports the government negotiating directly with drug companies on prices for drugs covered by the Medicare insurance program, the White House said on Tuesday. "He's for it," White House spokesman Sean Spicer said, when asked at a briefing whether Trump still supports negotiating drug prices for the healthcare program. Spicer said Trump was committed to using his "skills as a businessman" to drive prices down.
Teva Pharmaceutical Industries was left without a permanent chief executive on Tuesday after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps. Teva, Israel's largest company, said late on Monday that Vigodman was departing immediately and would be replaced on an interim basis by Chairman Yitzhak Peterburg. Investors say Teva, which faces pricing pressure in its core generics business and recently lost patent protection on its key branded drug Copaxone for multiple sclerosis, must choose a new CEO with extensive pharmaceutical experience.
No comments:
Post a Comment